{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:44Z","timestamp":1791967844244,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006388","name":"Geneva University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007292","name":"Nurses Organization of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ebiom.2026.106477","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:20:48Z","timestamp":1789143648000},"page":"106477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study"],"prefix":"10.1016","volume":"132","author":[{"given":"Manuela","family":"Undurraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Koessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Diciolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Raimond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Genoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6377-0352","authenticated-orcid":false,"given":"Valentine","family":"Du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Tille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Bornand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-671X","authenticated-orcid":false,"given":"Jonathan S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Smekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Terzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Christinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Veillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Tsantoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thoueille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Monig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Petignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Toso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Decosterd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-3475","authenticated-orcid":false,"given":"Intidhar","family":"Labidi-Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Ris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2026.106477_bib1","first-page":"49","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106477_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106477_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106477_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215914","article-title":"The molecular biology of peritoneal metastatic disease","volume":"15","author":"Bootsma","year":"2023","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106477_bib5","article-title":"Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases","volume":"5","author":"Bootsma","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106477_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41416-024-02717-4","article-title":"Metastasis-associated fibroblasts in peritoneal surface malignancies","volume":"131","author":"Ramos","year":"2024","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106477_bib7","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-23-3964","article-title":"Clinical challenges of consensus molecular subtype CMS4 Colon cancer in the era of precision medicine","volume":"30","author":"Mouillet-Richard","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106477_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/pp-2016-0023","article-title":"Morphology of the peritoneal cavity and pathophysiological consequences","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106477_bib9","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106477_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106477_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1245\/s10434-021-10505-0","article-title":"PIPAC for the treatment of gynecologic and gastrointestinal peritoneal metastases: technical and logistic considerations of a phase 1 trial","volume":"29","author":"Raoof","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106477_bib12","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","article-title":"PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106477_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ebiom.2026.106477_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2020.09.010","article-title":"A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers","volume":"140","author":"Dumont","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2026.106477_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104151","article-title":"Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases","volume":"82","author":"Ceelen","year":"2022","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106477_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103681","article-title":"Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes","volume":"9","author":"Sundar","year":"2024","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106477_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.critrevonc.2014.06.001","article-title":"Nab-paclitaxel: a flattering facelift","volume":"92","author":"Viudez","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106477_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00280-019-03767-9","article-title":"A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity","volume":"83","author":"Cristea","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106477_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067691","article-title":"Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity","volume":"13","author":"Lang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ebiom.2026.106477_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106477_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/his.13829","article-title":"Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis","volume":"74","author":"Solass","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106477_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ebiom.2026.106477_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2026.106477_bib24","article-title":"Geneva homologous recombination deficiency test is predictive of survival benefit from olaparib and bevacizumab maintenance in ovarian cancer","volume":"9","author":"Christinat","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ebiom.2026.106477_bib25","article-title":"Normalized LST is an efficient biomarker for homologous recombination deficiency and olaparib response in ovarian carcinoma","volume":"7","author":"Christinat","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106477_bib26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ejso.2018.04.020","article-title":"Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis","volume":"44","author":"Tempfer","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106477_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/ijgc-2021-002467","article-title":"Metronomic oral cyclophosphamide in relapsed ovarian cancer","volume":"31","author":"Spiliopoulou","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106477_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MPA.0000000000001857","article-title":"Incidence, treatment, and survival of synchronous peritoneal metastases in pancreatic cancer: update of a nationwide cohort","volume":"50","author":"Rijken","year":"2021","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106477_bib29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10120-021-01160-1","article-title":"Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort","volume":"24","author":"Koemans","year":"2021","journal-title":"Gastric Cancer"},{"issue":"31","key":"10.1016\/j.ebiom.2026.106477_bib30","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1200\/JCO.2004.00.6148","article-title":"Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies","volume":"23","author":"Nyman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106477_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"8_Suppl_1","key":"10.1016\/j.ebiom.2026.106477_bib32","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1158\/1538-7445.AM2025-6541","article-title":"Spatial and longitudinal characterization of tumor microenvironment of peritoneal carcinomatosis: Nab-PIPAC phase IB trial","volume":"85","author":"Grassi","year":"2025","journal-title":"Cancer Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:19:21Z","timestamp":1791965961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S2352396426003610"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106477","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106477"}}